Probiotec Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Probiotec Limited with three other
pharmaceutical manufacturers in Australasia:
Regeneus Ltd
(2021
sales of 7.07 million Australian Dollars [US$5.15 million]
),
AFT Pharmaceuticals Ltd
of NEW ZEALAND
(113.11 million New Zealand Dollars [US$79.76 million]
of which 60%
was Australia), and
Blis Technologies Ltd
which is
also
based in NEW ZEALAND
(10.61 million New Zealand Dollars [US$7.48 million]
).
Sales Analysis.
Probiotec Limited reported sales of A$120.51 million (US$87.83 million)
for the
fiscal
year ending
June of 2021.
This
represents
an
increase of 12.4%
versus 2020, when the company's sales were A$107.22 million.
This was the fourth straight year of sales growth at Probiotec Limited.